These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2888454)
21. [Cortisol levels in plasma and aqueous humour of patients with steroid induced and other glaucomas]. Kasimov EM; Aghaeva FA Vestn Oftalmol; 2017; 133(2):39-45. PubMed ID: 28524138 [TBL] [Abstract][Full Text] [Related]
22. Differences of adrenal stress control mechanisms in subjects with glaucoma and normal subjects. Effect of vasopressin and pyrogen. Schwartz B; Golden MA; Wiznia RA; Miller SA Arch Ophthalmol; 1981 Oct; 99(10):1770-7. PubMed ID: 7295125 [TBL] [Abstract][Full Text] [Related]
24. Central corneal thickness measurements in patients with normal tension glaucoma, primary open angle glaucoma, pseudoexfoliation glaucoma, or ocular hypertension. Ventura AC; Böhnke M; Mojon DS Br J Ophthalmol; 2001 Jul; 85(7):792-5. PubMed ID: 11423450 [TBL] [Abstract][Full Text] [Related]
25. One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension. Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Fukushima A; Suganami H; Araie M; Acta Ophthalmol; 2016 Feb; 94(1):e26-34. PubMed ID: 26338317 [TBL] [Abstract][Full Text] [Related]
26. Color Doppler imaging in ocular hypertension and open-angle glaucoma. Akarsu C; Bilgili MYK Graefes Arch Clin Exp Ophthalmol; 2004 Feb; 242(2):125-129. PubMed ID: 14663592 [TBL] [Abstract][Full Text] [Related]
27. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Fuchsjäger-Mayrl G; Wally B; Georgopoulos M; Rainer G; Kircher K; Buehl W; Amoako-Mensah T; Eichler HG; Vass C; Schmetterer L Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):834-9. PubMed ID: 14985298 [TBL] [Abstract][Full Text] [Related]
28. [Comparative study of levobunolol and timolol in the treatment of chronic open-angle glaucoma and chronic ocular hypertension]. Savelsbergh-Fillette MP; Demailly P J Fr Ophtalmol; 1988; 11(8-9):587-90. PubMed ID: 2906644 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Varma R; Ying-Lai M; Francis BA; Nguyen BB; Deneen J; Wilson MR; Azen SP; Ophthalmology; 2004 Aug; 111(8):1439-48. PubMed ID: 15288969 [TBL] [Abstract][Full Text] [Related]
31. An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension. Stewart WC; Leech J; Sharpe ED; Kulze J; Ellyn J; Day DG Am J Manag Care; 2002 Aug; 8(10 Suppl):S240-8. PubMed ID: 12188166 [TBL] [Abstract][Full Text] [Related]
32. Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol. Southren AL; l'Hommedieu D; Gordon GG; Weinstein BI Invest Ophthalmol Vis Sci; 1987 May; 28(5):901-3. PubMed ID: 3570698 [TBL] [Abstract][Full Text] [Related]
33. Association of ocular hypotensive medication types with dynamic contour tonometry and Goldmann applanation tonometry measurements in a glaucoma and ocular hypertensive population. Tzamalis A; Kynigopoulos M; Chalvatzis N; Dimitrakos S; Schlote T J Ocul Pharmacol Ther; 2013 Feb; 29(1):41-7. PubMed ID: 23066787 [TBL] [Abstract][Full Text] [Related]
34. Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage. Jonas JB; Stroux A; Martus P; Budde W J Glaucoma; 2006 Jun; 15(3):206-12. PubMed ID: 16778642 [TBL] [Abstract][Full Text] [Related]
35. [Depression of plasma cortisol and primary open-angle glaucoma (author's transl)]. Zou XL Zhonghua Yan Ke Za Zhi; 1982 Jan; 18(1):1-4. PubMed ID: 6806037 [No Abstract] [Full Text] [Related]
36. Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients. Renard P; Kovalski JL; Cochereau I; Jaulerry S; Williamson W; Elena PP; Lablache Combier M; Allaire C; Siou-Mermet R Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1221-7. PubMed ID: 16003515 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension. Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922 [TBL] [Abstract][Full Text] [Related]
38. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Garbe E; LeLorier J; Boivin JF; Suissa S Lancet; 1997 Oct; 350(9083):979-82. PubMed ID: 9329512 [TBL] [Abstract][Full Text] [Related]
39. Plasma lipid patterns in patients with suspected glaucoma. Chisholm IA; Stead S Can J Ophthalmol; 1988 Jun; 23(4):164-7. PubMed ID: 3395919 [TBL] [Abstract][Full Text] [Related]
40. A comparison of retinal and choroidal hemodynamics in patients with primary open-angle glaucoma and normal-pressure glaucoma. Duijm HF; van den Berg TJ; Greve EL Am J Ophthalmol; 1997 May; 123(5):644-56. PubMed ID: 9152070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]